RxDoctor Payments Data

Jean-Maria Langley, DO

Otolaryngology/Facial Plastic Surgery · Tulsa, OKNPI 1831352723

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,478 of the $4,537 with a category attached, or 76.6%. 15 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 46.4% of the total. Reporting peaked in 2023 at $2,179 and has fallen 68.1% since, to $694 in 2025.

$4,537in general payments, 2019–2025

Across 107 payments — averaging $42.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Sanofi$762
  • Regeneron Healthcare Solutions, Inc.$503
  • Intersect ENT, Inc.$260
  • Stryker$246
  • Aerin Medical Inc.$210
  • plus $450 from 9 others

What the payments were for

  • Travel & lodging$1,00422%
  • Food & beverage$3,47877%
  • Education$561%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$80,294
Medicare patients
186
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole93$1,871
Pantoprazole Sodium119$1,743
Fluticasone Propionate100$1,448
Famotidine64$1,373
Azelastine Hcl45$963
Ipratropium Bromide44$885
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$482
Levocetirizine Dihydrochloride46$300
Mupirocin13$268
Promethazine Hcl42$263
Diazepam21$163
Azithromycin26$91
Prednisone20$68

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →